Physical activity and training in sarcoidosis: review and experience-based recommendations

References

• Holland AE, Hill CJ, Glaspole I, et al. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med. 2012;106:429–435.
   PubMed Web of Science ®Google Scholar
• Holland AE, Wadell K, Spruit MA. How to adapt the pulmonary rehabilitation programme to patients with chronic respiratory disease other than COPD. Eur Respir Rev. 2013;22:577–586.
   PubMedGoogle Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.
   PubMed Web of Science ®Google Scholar
• Swigris JJ, Brown KK, Make BJ, et al. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008;102:1675–1680.
   PubMed Web of Science ®Google Scholar
• Swigris JJ, Fairclough DL, Morrison M, et al. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care. 2011;56:783–789.
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1–72.
   PubMed Web of Science ®Google Scholar
• Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014;383:1155–1167.
   PubMed Web of Science ®Google Scholar
• Judson MA, Mack M, Beaumont JL, et al. Validation and important differences for the sarcoidosis assessment tool. A new patient-reported outcome measure. Am J Respir Crit Care Med. 2015;191:786–795.
   PubMed Web of Science ®Google Scholar
• Judson MA. The clinical features of sarcoidosis: a comprehensive review. Clin Rev Allergy Immunol. 2015;49:63–78.
   PubMed Web of Science ®Google Scholar
• Drent M, Strookappe B, Hoitsma E, et al. Consequences of sarcoidosis. Clin Chest Med. 2015;36:727–737.
   PubMed Web of Science ®Google Scholar
• Marcellis RG, Lenssen AF, Elfferich MD, et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J. 2011;38:628–634.
   PubMed Web of Science ®Google Scholar
• De Vries J, Drent M. Quality of life and health status in sarcoidosis: a review of the literature. Clin Chest Med. 2008;29:525–532.
   PubMed Web of Science ®Google Scholar
• Judson MA. Quality of life assessment in Sarcoidosis. Clin Chest Med. 2015;36:739–750.
   PubMed Web of Science ®Google Scholar
• Patel AS, Siegert RJ, Creamer D, et al. The development and validation of the King’s sarcoidosis questionnaire for the assessment of health status. Thorax. 2013;68:57–65.
   PubMed Web of Science ®Google Scholar
• De Vries J, Wirnsberger RM. Fatigue, quality of life and health status in sarcoidosis. Eur Respir Mon. 2005;32:92–104.
   Google Scholar
• De Vries J, Drent M. Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:57–63.
   PubMed Web of Science ®Google Scholar
• Drent M, Marcellis R, Lenssen A, et al. Association between physical functions and quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:117–128.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax. 2005;60:32–38.
   PubMed Web of Science ®Google Scholar
• Panagiotou M, Polychronopoulos V, Strange C. Respiratory and lower limb muscle function in interstitial lung disease. Chron Respir Dis. 2016;13:162–172.
   PubMed Web of Science ®Google Scholar
• Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J. 2012;40:255–263.
   PubMed Web of Science ®Google Scholar
• Huppmann P, Sczepanski B, Boensch M, et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J. 2013;42:444–453.
   PubMed Web of Science ®Google Scholar
• Marcellis RG, Veeke MAF, Mesters I, et al. Does physical training reduce fatigue in sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis. 2015;32:53–62.
   PubMed Web of Science ®Google Scholar
• Strookappe B, Swigris J, De Vries J, et al. Benefits of physical training in Sarcoidosis. Lung. 2015;193:701–708.
   PubMed Web of Science ®Google Scholar
• Karadalli MN, Bosnak-Guclu M, Camcioglu B, et al. Effects of inspiratory muscle training in subjects with sarcoidosis: a randomized controlled clinical trial. Respir Care. 2015;61:483–494.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500–1524.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e1000251.
   PubMed Web of Science ®Google Scholar
• Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235–1241.
   PubMed Web of Science ®Google Scholar
• Roddy E, Zhang W, Doherty M, et al. Evidence-based clinical guidelines: a new system to better determine true strength of recommendation. J Eval Clin Pract. 2006;12:347–352.
   PubMed Web of Science ®Google Scholar
• Strookappe B, Elfferich M, Swigris J, et al. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32:43–52.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Drent M, Culver DA, et al. Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:90–98.
   PubMed Web of Science ®Google Scholar
• Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31:1189–1196.
   PubMed Web of Science ®Google Scholar
• Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.
   PubMed Web of Science ®Google Scholar
• Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219–229.
   PubMed Web of Science ®Google Scholar
• Ding D, Lawson KD, Kolbe-Alexander TL, et al. The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet. 2016; [Epub ahead of print]. DOI:10.1016/S0140-6736(16)30383-X
   Web of Science ®Google Scholar
• Drent M. Sarcoidosis: benefits of a multidisciplinary approach. Eur J Intern Med. 2003;14:217–220.
   PubMedGoogle Scholar
• Korenromp IH, Heijnen CJ, Vogels OJ, et al. Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest. 2011;140:441–447.
   PubMed Web of Science ®Google Scholar
• Michielsen HJ, Peros-Golubicic T, Drent M, et al. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration. 2007;74:401–405.
   PubMed Web of Science ®Google Scholar
• De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, et al. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:127–136.
   PubMed Web of Science ®Google Scholar
• De Boer S, Kolbe J, Wilsher ML. The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis. Respirology. 2014;19:1019–1024.
   PubMed Web of Science ®Google Scholar
• Wirnsberger RM, De Vries J, Jansen TL, et al. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med. 1999;54:86–95.
   PubMed Web of Science ®Google Scholar
• Bosse-Henck A, Wirtz H, Hinz A. Subjective sleep quality in sarcoidosis. Sleep Med. 2015;16:570–576.
   PubMed Web of Science ®Google Scholar
• Verbraecken J, Hoitsma E, van der Grinten CP, et al. Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:137–146.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Engel PJ, Nathan S. Pulmonary hypertension in sarcoidosis. Clin Chest Med. 2015;36:703–714.
   PubMed Web of Science ®Google Scholar
• Rp B, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest. 2007;132:207–213.
   PubMed Web of Science ®Google Scholar
• Marcellis RG, Lenssen AF, de Vries J, et al. Reduced muscle strength, exercise intolerance and disabling symptoms in sarcoidosis. Curr Opin Pulm Med. 2013;19:524–530.
   PubMed Web of Science ®Google Scholar
• Jastrzebski D, Ziora D, Lubecki M, et al. Fatigue in sarcoidosis and exercise tolerance, dyspnea, and quality of life. Adv Exp Med Biol. 2015;833:31–36.
   PubMed Web of Science ®Google Scholar
• Hinz A, Brähler E, Möde R, et al. Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:139–146.
   PubMed Web of Science ®Google Scholar
• Kabitz HJ, Lang F, Walterspacher S, et al. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest. 2006;130:1496–1502.
   PubMed Web of Science ®Google Scholar
• Van Manen MJ, Wapenaar M, Strookappe B, et al. Validation of the King’s Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:75–82.
   PubMed Web of Science ®Google Scholar
• Wirnsberger RM, de Vries J, Breteler MH, et al. Evaluation of quality of life in sarcoidosis patients. Respir Med. 1998;92:750–756.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–1889.
   PubMed Web of Science ®Google Scholar
• Holland AE, Dowman LM, Hill CJ. Principles of rehabilitation and reactivation: interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement. Respiration. 2015;89:89–99.
   PubMed Web of Science ®Google Scholar
• Wirnsberger RM, Drent M, Hekelaar N, et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J. 1997;10:1450–1455.
   PubMed Web of Science ®Google Scholar
• Baydur A, Alsalek M, Louie SG, et al. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest. 2001;120:102–108.
   PubMed Web of Science ®Google Scholar
• Bohannon RW. Test-retest reliability of hand-held dynamometry during a single session of strength assessment. Phys Ther. 1986;66:206–209.
   PubMed Web of Science ®Google Scholar
• Cremers JP, Drent M, Elfferich MD, et al. Body composition profiling in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30:289–299.
   PubMed Web of Science ®Google Scholar
• Cremers JP, Van Kroonenburgh MJ, Mostard RL, et al. Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:37–45.
   PubMed Web of Science ®Google Scholar
• Silverstein A, Siltzbach LE. Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol. 1969;21:235–241.
   PubMedGoogle Scholar
• Wirnsberger RM, de Vries J, Wouters EF, et al. Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med. 1998;53:53–60.
   PubMed Web of Science ®Google Scholar
• Costabel U. Skeletal muscle weakness, fatigue and sarcoidosis. Thorax. 2005;60:1–2.
   PubMed Web of Science ®Google Scholar
• Walterspacher S, Schlager D, Walker DJ, et al. Respiratory muscle function in interstitial lung disease. Eur Respir J. 2013;42:211–219.
   PubMed Web of Science ®Google Scholar
• Hoitsma E, Marziniak M, Faber CG, et al. Small fibre neuropathy in sarcoidosis. Lancet. 2002;359:2085–2086.
   PubMed Web of Science ®Google Scholar
• Elfferich MD, Nelemans PJ, Ponds RW, et al. Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration. 2010;80:212–219.
   PubMed Web of Science ®Google Scholar
• Hoitsma E, De Vries J, Drent M. The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir Med. 2011;105:95–100.
   PubMed Web of Science ®Google Scholar
• Judson MA. Small fiber neuropathy in sarcoidosis: something beneath the surface. Respir Med. 2011;105:1–2.
   PubMed Web of Science ®Google Scholar
• Hoitsma E, Drent M, Sharma OP. A pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century. Curr Opin Pulm Med. 2010;16:472–479.
   PubMed Web of Science ®Google Scholar
• Tavee J, Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep. 2011;15:201–206.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol. 2012;8:95–103.
   PubMed Web of Science ®Google Scholar
• Elfferich MD, De Vries J, Drent M. Type D or ‘distressed’ personality in sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28:65–71.
   PubMed Web of Science ®Google Scholar
• Saligan LN. The relationship between physical activity, functional performance and fatigue in sarcoidosis. J Clin Nurs. 2014;23:2376–2378.
   PubMed Web of Science ®Google Scholar
• Michielsen HJ, Drent M, Peros-Golubicic T, et al. Fatigue is associated with quality of life in sarcoidosis patients. Chest. 2006;130:989–994.
   PubMed Web of Science ®Google Scholar
• Brancaleone P, Perez T, Robin S, et al. Clinical impact of inspiratory muscle impairment in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:219–227.
   PubMed Web of Science ®Google Scholar
• Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014;108:203–210.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Wouters EFM, Gosselink R. Rehabilitation programmes in sarcoidosis: a multidisciplinary approach. Eur Respir Mon. 2005;32:316–326.
   Google Scholar
• Holland AE, Hill CJ, Conron M, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63:549–554.
   PubMed Web of Science ®Google Scholar
• Panagiotou M, Peacock AJ, Johnson MK. Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training? Pulm Circ. 2015;5:424–434.
   PubMed Web of Science ®Google Scholar
• Hebestreit H, Kriemler S, Radtke T. Exercise for all cystic fibrosis patients: is the evidence strengthening? Curr Opin Pulm Med. 2015;21:591–595.
   PubMed Web of Science ®Google Scholar
• Boots AW, Drent M, de Boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr. 2011;30:506–512.
   PubMed Web of Science ®Google Scholar
• Rammaert B, Leroy S, Cavestri B, et al. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis. Rev Mal Respir. 2011;28:e52–57.
   PubMed Web of Science ®Google Scholar
• Lingner H, Grosshennig A, Flunkert K, et al. ProKaSaRe study protocol: a prospective multicenter study of pulmonary rehabilitation of patients with sarcoidosis. JMIR Res Protoc. 2015;4:e134.
   PubMed Web of Science ®Google Scholar